Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-20

Clinical Trial Update: Patiromer With or Without Food for the Treatment of Hyperkalemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating patiromer with or without food for treatment of hyperkalemia has completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Patiromer (patiromer)

Snippet

Sponsor: Relypsa, Inc. | Conditions: Hyperkalemia | Phase 4 | Status: COMPLETED | Results posted: 2017-11-20